Skip to Content
Merck
All Photos(1)

Documents

714208

Sigma-Aldrich

L-Allysine ethylene acetal

≥98% (TLC)

Synonym(s):

(S)-2-Amino-5-(1,3-dioxolan-2-yl)pentanoic acid

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C8H15NO4
CAS Number:
215054-80-1
Molecular Weight:
189.21
MDL number:
MFCD07778443
UNSPSC Code:
12352209
PubChem Substance ID:
329763261
NACRES:
NA.22

Assay

≥98% (TLC)

form

crystals

optical activity

[α]/D +4.0±0.3°, c = 1 in H2O

reaction suitability

reaction type: solution phase peptide synthesis

application(s)

peptide synthesis

SMILES string

N[C@@H](CCCC1OCCO1)C(O)=O

InChI

1S/C8H15NO4/c9-6(8(10)11)2-1-3-7-12-4-5-13-7/h6-7H,1-5,9H2,(H,10,11)/t6-/m0/s1

InChI key

RQULWPSGQYZREI-LURJTMIESA-N

Packaging

Bottomless glass bottle. Contents are inside inserted fused cone.

Storage Class Code

11 - Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Elizabeth Mary Mathew et al.
International journal of analytical chemistry, 2018, 2583215-2583215 (2018-08-30)
Pyridoxine dependent epilepsy is a condition where the affected infant or child has prolonged seizures (status epilepticus), which are nonresponsive to anticonvulsant therapy but can be treated with pharmacological doses of pyridoxine. If identified earlier and treated prophylactically with pyridoxine
Michael F Wempe et al.
Journal of inherited metabolic disease, 42(3), 565-574 (2019-01-22)
Pyridoxine-dependent epilepsy (PDE) is often characterized as an early onset epileptic encephalopathy with dramatic clinical improvement following pyridoxine supplementation. Unfortunately, not all patients present with classic neonatal seizures or respond to an initial pyridoxine trial, which can result in the

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service